chitosan has been researched along with Hypercholesterolemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Abdo, A; Al-Dalali, S; Al-Zamani, Z; Aleryani, H; Gao, J; Hou, Y; Saleh, A; Sang, Y; Yahya, MA; Zhang, C | 1 |
| Chiang, MT; Chiu, CY; Liu, SH; Yen, TE | 1 |
| Chen, L; Wang, C; Wu, Y | 1 |
| Chi, H; Huang, H; Liao, D; Zou, Y | 1 |
| Azuma, K; Ifuku, S; Imagawa, T; Ito, N; Izawa, H; Morimoto, M; Murahata, Y; Nagae, T; Nagai, T; Okamoto, Y; Osaki, T; Saimoto, H; Tsuka, T | 1 |
| Li, L; Liu, J; Xia, W; Zhang, J | 1 |
| Anglade, M; Baker, WL; Coleman, CI; Tercius, A; White, CM | 1 |
| Bokura, H; Kobayashi, S | 1 |
| Modrzejewska, Z; Zarzycki, R | 1 |
| Bryant, PJ; McQueen, CE; Shields, KM; Smock, N | 1 |
| Lehtimäki, T; Metso, S; Nikkilä, M; Rontu, R; Wuolijoki, E; Ylitalo, P; Ylitalo, R | 1 |
| Afros, F; Hashimoto, M; Hossain, S; Kabir, Y; Rahman, A; Shams, AA | 1 |
| Jaffer, S; Sampalis, JS | 1 |
| Kolehmainen, RM; Lyyra, ML; Sarkkinen, ES; Schauss, AG; Tapola, NS | 1 |
| Holmes, CC; Miller, TE; Ormrod, DJ | 1 |
| Muzzarelli, RA | 1 |
| Chiang, MT; Lee, WJ; Sheu, WH; Tai, TS; Yao, HT | 1 |
| Eng, PH; Fok, AC; Ho, SC; Tai, ES; Tan, CE | 1 |
| Lehtimäki, T; Lehtinen, S; Wuolijoki, E; Ylitalo, P; Ylitalo, R | 1 |
6 review(s) available for chitosan and Hypercholesterolemia
| Article | Year |
|---|---|
Lipid-Modifying Effects of Chitosan Supplementation in Humans: A Pooled Analysis with Trial Sequential Analysis.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Chitosan; Dietary Supplements; Evidence-Based Medicine; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic | 2018 |
A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients.
Topics: Anticholesteremic Agents; Chitosan; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic; Treatment Outcome; Triglycerides | 2009 |
[Use of chitosan in medicine and biomedical engineering].
Topics: Artificial Organs; Bandages; Biomedical Engineering; Blood Component Removal; Chitin; Chitosan; Drug Carriers; Drug Utilization; Humans; Hypercholesterolemia; Poland; Renal Dialysis; Surface Properties | 2003 |
Chitosan for weight loss and cholesterol management.
Topics: Anticholesteremic Agents; Appetite Depressants; Chitin; Chitosan; Clinical Trials as Topic; Humans; Hypercholesterolemia; Weight Loss | 2003 |
Clinical and biochemical evaluation of chitosan for hypercholesterolemia and overweight control.
Topics: Animals; Anticholesteremic Agents; Appetite Depressants; Chitin; Chitosan; Humans; Hypercholesterolemia; Intestinal Absorption; Mice; Obesity | 1999 |
Cholesterol-lowering properties and safety of chitosan.
Topics: Animals; Anticholesteremic Agents; Chitin; Chitosan; Delayed-Action Preparations; Humans; Hypercholesterolemia | 2002 |
6 trial(s) available for chitosan and Hypercholesterolemia
| Article | Year |
|---|---|
Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Anticholesteremic Agents; Chitin; Chitosan; Cholesterol; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hypercholesterolemia; Middle Aged; Patient Compliance; Placebos | 2003 |
Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: a long-term placebo-controlled trial in hypercholesterolaemic volunteers.
Topics: Adolescent; Adult; Aged; Apolipoprotein E4; Apolipoproteins E; Blood Glucose; Chitosan; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Genotype; Heterozygote; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged | 2005 |
Efficacy and safety of chitosan HEP-40 in the management of hypercholesterolemia: a randomized, multicenter, placebo-controlled trial.
Topics: Analysis of Variance; Anticholesteremic Agents; Chitosan; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 2007 |
Safety aspects and cholesterol-lowering efficacy of chitosan tablets.
Topics: Adolescent; Adult; Anticholesteremic Agents; Carotenoids; Chitosan; Cholesterol; Dose-Response Relationship, Drug; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E | 2008 |
Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
Topics: Anticholesteremic Agents; Blood Glucose; Chitin; Chitosan; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Hypoglycemic Agents; Lipoproteins; Placebos; Triglycerides | 2000 |
In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects.
Topics: Adult; Anticholesteremic Agents; Body Weight; Chitin; Chitosan; Cholesterol; Cholesterol, HDL; Diet; Double-Blind Method; Female; Humans; Hypercholesterolemia; Life Style; Lipids; Male; Obesity | 2001 |
7 other study(ies) available for chitosan and Hypercholesterolemia
| Article | Year |
|---|---|
Marine Chitosan-Oligosaccharide Ameliorated Plasma Cholesterol in Hypercholesterolemic Hamsters by Modifying the Gut Microflora, Bile Acids, and Short-Chain Fatty Acids.
Topics: Animals; Bile Acids and Salts; Chitosan; Cholesterol; Cricetinae; Fatty Acids, Volatile; Gastrointestinal Microbiome; Hypercholesterolemia; Liver; Male; Mesocricetus; Oligosaccharides | 2023 |
Comparative Effects and Mechanisms of Chitosan and Its Derivatives on Hypercholesterolemia in High-Fat Diet-Fed Rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chitosan; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet, High-Fat; Hypercholesterolemia; Liver; Male; PPAR alpha; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Tumor Necrosis Factor-alpha | 2019 |
Cholesterol (Blood lipid) lowering potential of Rosuvastatin chitosan nanoparticles for atherosclerosis: Preclinical study in rabbit model.
Topics: Animals; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Biomarkers; Calcinosis; Calcium; Chitosan; Cholesterol; Cholesterol, LDL; Cholic Acid; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Hypercholesterolemia; Interleukin-6; Male; Nanoparticles; Particle Size; Rabbits; Rosuvastatin Calcium; Treatment Outcome | 2020 |
Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Cellulose; Chitin; Chitosan; Cholesterol; Humans; Hypercholesterolemia; Lipoproteins, VLDL; Nanofibers; Phospholipids; Rats | 2015 |
Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets.
Topics: Animals; Anticholesteremic Agents; Body Weight; Brachyura; Cecum; Chitosan; Diet, Atherogenic; Dietary Fats; Eating; Feces; Hydrogen-Ion Concentration; Hypercholesterolemia; Lipase; Lipids; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Effects of shrimp (Macrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Chitosan; Dealkylation; Diet; Eating; Fatty Acids; Female; Hypercholesterolemia; Lipid Peroxides; Lipids; Liver; Penaeidae; Rats; Rats, Long-Evans | 2007 |
Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; Body Weight; Chitin; Chitosan; Diet; Disease Models, Animal; Hypercholesterolemia; Mice; Mice, Knockout | 1998 |